text:
Originalarbeiten / Original papers
E.A. Idelevich, H. Seifert, M. Sundqvist, L. Scudeller, S. Amit, A. Balode, A. Bilozor, P. Drevinek, Z.K.Tufan, A. Koraqi, B. Lamy, I. Mareković, J. Miciuleviciene, M.M. Premru, A. Pascual, S. Pournaras, V. Saegeman, H.C. Schønheyder, J. Schrenzel, T. Strateva, R. Tilley, W.J. Wiersinga, D. Zabicka, Y. Carmeli, K. Becker K, ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES). Microbiological diagnostics of bloodstream infections in Europe - An ESGBIES survey. Clin. Microbiol. Infect. 2019 [Epub ahead of print]
F. Schaumburg, S. Sertic, C. Correa-Martinez, A. Mellmann, R. Köck, K. Becker. Acquisition and colonization dynamics of antimicrobial-resistant bacteria during international travel: a prospective cohort study. Clin. Microbiol. Infect. 2019 [Epub ahead of print]
N. Schleimer, U. Kaspar, D. Knaack, C. von Eiff, S. Molinaro, H. Grallert, E.A. Idelevich, K. Becker. In vitro activity of the bacteriophage endolysin HY-133 against Staphylococcus aureus small-colony variants and their corresponding wild types. Int. J. Mol. Sci. 2019 20(3) pii: E716
C.L. Correa-Martínez, E.A. Idelevich, K. Sparbier, M. Kostrzewa, K. Becker. Rapid detection of extended-spectrum beta-lactamases (ESBL) and AmpC beta-lactamases in Enterobacterales: Development of a screening panel using the MALDI-TOF MS-based direct-on-target microdroplet growth assay. Frontiers Microbiol. 2019 10:13
N. Schleimer, U. Kaspar, B. Ballhausen, S.A. Fotiadis, J.M. Streu, A. Kriegeskorte, R.A. Proctor, K. Becker. Adaption of an episomal antisense silencing approach for investigation of the phenotype switch of Staphylococcus aureus small-colony variants. Front. Microbiol. 2019 10:2044. eCollection 2019
D. Knaack, E.A. Idelevich, N. Schleimer, S. Molinaro, A. Kriegeskorte, G. Peters, K. Becker. Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis. Diagn. Microbiol. Infect. Dis. 2019 93(4):362-368
U. Kaspar, K. von Lützau, A. Schlattmann, U. Rösler, R. Köck, K. Becker. Zoonotic multidrug-resistant microorganisms among non-hospitalized horses from Germany. One Health2019 7:100091, eCollection 2019
A. Jurke, I. Daniels-Haardt, W. Silvis, M.S. Berends, C. Glasner, K. Becker, R. Köck, A.W. Friedrich. Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the Dutch-German border region, 2012 to 2016: results of the search-and-follow-policy. Euro Surveill. 2019 24(15) doi: 10.2807/1560-7917.ES.2019.24.15.1800244
F. Schaumburg, S. Bletz, A. Mellmann, K. Becker, E. A. Idelevich. Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam. Int. J. Antimicrob. Agents. 2019 54(2):255-260
A. Olalekan, F. Onwugamba, B. Iwalokun, A. Mellmann, K. Becker, F. Schaumburg. High proportion of carbapenemase producing Escherichia coli and Klebsiella pneumoniae among extended spectrum beta-lactamase producers in Nigerian hospitals. J. Glob. Antimicrob. Resist. 2019 pii: S2213-7165(19)30240-1
E.A. Idelevich, D. Knaack, N.T. Nugroho, G. Peters, T. Bisdas, S. Molinaro, G.B. Torsello, K. Becker, M. Herten. Comparative in vitro activity of bacteriophage endolysin HY-133 against Staphylococcus aureus attached to vascular graft surface. Med Microbiol Immunol. 2019 [Epub ahead of print]
J. Keizer; L.M. Braakman-Jansen; S. Kampmeier; R. Köck; N. Al Naiemi; R. Te Riet-Warning; N. Beerlage-De Jong; K. Becker; J.E. Van Gemert-Pijnen. Cross-border comparison of antimicrobial resistance (AMR) and AMR prevention measures: the healthcare workers' perspective. Antimicrob Resist Infect Control. 2019 8:123
M. Kosecka-Strojek, A.J. Sabat, V. Akkerboom, K. Becker, E. Van Zanten, G. Wisselink, J. Miedzobrodzki, M. Kooistra-Smid, A.W. Friedrich. Development and validation of a reference data set for assigning Staphylococcus species based on next-generation sequencing of the 16S-23S rRNA region. Front Cell Infect Microbiol. 2019 9:278
A. Apsemidou, K. Rauwolf, A. Tragiannidis, A. Brentrup, M. Schiborr, K. Becker, M. Ahlmann, A.H. Groll. Disseminated Bartonella henselae disease mimicking Langerhans' cell histiocytosis. Pediatr Blood Cancer. e27573 [Epub ahead of print]
A. Pérez-Hansen, C. Lass-Flörl, M. Lackner; Rare Yeast Study Group (M. Aigner, A. Alastruey-Izquierdo, S. Arikan-Akdagli, O. Bader, K. Becker, T. Boekhout, W. Buzina, O.A. Cornely, P. Hamal, S.E. Kidd, O. Kurzai, K. Lagrou, A. Lopes Colombo, M. Mares, H. Masoud, J.F. Meis, S. Oliveri, A.C. Rodloff, D. Orth-Höller, I. Guerrero-Lozano, M. Sanguinetti, E. Segal, S.J. Taj-Aldeen, A.M. Tortorano, L. Trovato, G. Walther, B. Willinger). Antifungal susceptibility profiles of rare ascomycetous yeasts. J Antimicrob Chemother. 2019 74(9):2649-56
E.A. Idelevich, K. Sparbier, M. Kostrzewa, K. Becker. Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay. Clin. Microbiol. Infect. 2018 24(7):738-43
E.A. Idelevich, L.M. Storck, K. Sparbier, O. Drews, M. Kostrzewa, K. Becker. Rapid direct susceptibility testing from positive blood cultures by the MALDI-TOF MS-based direct-on-target microdroplet growth assay. J. Clin. Microbiol. 2018 56(10). pii: e00913-18
K. Becker, S. van Alen, E.A. Idelevich, N. Schleimer, J. Seggewiß, A. Mellmann, U. Kaspar, G. Peters. Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus. Emerg. Infect. Dis. 2018 24(2):242-8
N. Schleimer, U. Kaspar, M. Drescher, J. Seggewiß, C. von Eiff, R.A. Proctor, G. Peters, A. Kriegeskorte, K. Becker. The Energy-Coupling Factor Transporter Module EcfAA'T, a Novel Candidate for the Genetic Basis of Fatty Acid-Auxotrophic Small-Colony Variants of Staphylococcus aureus. Front. Microbiol. 2018 9:1863. doi: 10.3389/fmicb.2018.01863. eCollection 2018
A. Kriegeskorte, E.A. Idelevich, A. Schlattmann, F. Layer, B. Strommenger, O. Denis, G.K. Paterson, M.A. Holmes, G. Werner, K. Becker. Comparison of different phenotypic approaches to screen and detect mecC harboring methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2018 56(1):e00826-17
U. Kaspar, J.A. de Haro Sautto, S. Molinaro, G. Peters, E.A. Idelevich, K. Becker. The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA). Antimicrob Agents Chemother. 2018 62(7):pii:e00385-18
S. van Alen, B. Ballhausen, U. Kaspar, R. Köck, K. Becker. Prevalence and genomic structure of bacteriophage phi3 in human derived livestock-associated MRSA from 2000 to 2015. J. Clin. Microbiol. 2018 56(9). pii: e00140-18
U. Kaspar, A. von Lützau, A. Schlattmann, U. Roesler, R. Köck, K. Becker. Zoonotic multidrug-resistant microorganisms among small companion animals in Germany. PLoS ONE 2018 13(12):e0208364
C. Correa-Martinez, A. Brentrup, K. Hess, K. Becker, A. H. Groll, F. Schaumburg. First description of a local Coprinopsis cinerea skin and soft tissue infection. New Microbes New Infect. 2018 21:102-104
E. A. Idelevich, M. Hoy, D. Knaack, D. Görlich, G. Peters, M. Borowski, K. Becker. Direct determination of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa from positive blood cultures using laser scattering technology. Int. J. Antimicrob. Agents 51(2):221-6
S. van Alen, U. Kaspar, E.A. Idelevich, R. Köck, K. Becker. Increase of zinc resistance in German human derived livestock-associated MRSA between 2000 and 2014. Vet. Microbiol. 2018 214:7-12
A. Schlattmann, K. von Lützau, U. Kaspar, K. Becker. 'Rothia nasisuis' sp. nov., 'Dermabacter porcinasus' sp. nov., 'Propionibacterium westphaliense' sp. nov., and 'Tessaracoccus nasisuum' sp. nov., isolated from porcine nasal swabs in the Münster region, Germany. New Microbes New Infect. 2018 26: 114–117
R. Köck, P. Siemer, J. Esser, S. Kampmeier, M.S. Berends, C. Glasner, J.P. Arends, K. Becker, A.W. Friedrich. Defining multidrug resistance of Gram-negative bacteria in the Dutch-German border region - impact of national guidelines. Microorganisms 2018 6(11):1-8 pii: E11
D. Knaack, E.A. Idelevich, B. Körber-Irrgang, M. Kresken, K. Becker. Evaluation of a novel optical assay for rapid detection of methicillin-resistant Staphylococcus aureus in liquid culture. J. Microbiol. Meth. 2018 146:68-70
E.A. Idelevich, U. Groß, K. Becker*, O. Bader* [*contributed equally]. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus. Diagn. Microbiol. Infect. Dis. 2018 91(1):52-4
E.A. Idelevich, D.A. Freeborn, H. Seifert, K. Becker. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2018 91(4):360-2
G. Kampmeier, P.H. Arnemann, M. Hessler, L.M. Seidel, K. Becker, A. Morelli, S.W. Rehberg, C. Ertmer. Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock. Sci Rep. 2018 8(1):7105
A. Kossow; B. Stühmer; F. Schaumburg; K. Becker; B. Glatz; M. Möllers; S. Kampmeier; A. Mellmann. High prevalence of MRSA and Multi-resistant Gram-negative bacteria in refugees admitted to the hospital - but no hint of transmission. PLoS ONE 2018 13(5):e0198103
S.M. Przybysz, C. Correa-Martinez, R. Köck, K. Becker, F. Schaumburg. SuperPolymyxin™ medium for the screening of colistin-resistant Gram-negative bacteria in stool samples. Front. Microbiol. 2018 ;9:2809
H. Frickmann, A. Hahn, R. Skusa, N. Mund, V. Viehweger, T. Köller, K. Köller, N.G. Schwarz, K. Becker, P. Warnke, A. Podbielski. Comparison of the etiological relevance of Staphylococcus haemolyticus and Staphylococcus hominis. Eur. J. Clin. Microbiol. Infect. Dis. 2018 37(8):1539-45
K. Becker, F. Schaumburg, C. Fegeler, A.W. Friedrich, R. Köck, Prevalence of Multiresistant Microorganisms (PMM) Study Group.Staphylococcus aureus from the German general population is highly diverse. Int. J. Med. Microbiol. 2017 307:21-7
S. van Alen, B. Ballhausen, G. Peters, A.W. Friedrich, A. Mellmann, R. Köck, K. Becker. In the centre of an epidemic: Fifteen years of LA-MRSA CC398 at the University Hospital Münster. Vet. Microbiol. 2017 200:19-24
E.A. Idelevich, B. Grünastel, K. Becker. Rapid Detection and identification of candidemia by direct blood culturing on solid medium using lysis-centrifugation method combined with MALDI-TOF MS. J. Clin. Microbiol. 2017 55(1):97-100
E.A. Idelevich, M. Hoy, D. Görlich, D. Knaack, B. Grünastel, G. Peters, M. Borowski, K. Becker. Rapid phenotypic detection of microbial resistance in Gram-positive bacteria by a real-time laser scattering method. Front. Microbiol. 2017 8:1064 eCollection 2017
R. Köck; J. Wüllenweber; D. Horn; C. Lanckohr; K. Becker; E.A Idelevich. Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy. Antimicrob. Res. Infect Control 2017 6:12
F. Schaumburg, S. Bletz, A. Mellmann, K. Becker, E. Idelevich. Susceptibility of MDR Pseudomonas aeruginosa to ceftolozane/tazobactam and comparison of different susceptibility testing methods. J. Antimicrob. Chemother. 2017 2017 72(11):3079-84
F. Schaumburg, G. Peters, E. Wardelmann, K. Becker, J. Sperveslage. Evaluation of GenoType® MTBDRplus using extracted DNA from formalin-fixed paraffin-embedded specimens J. Clin. Microbiol. 2017 55(11):3300-2
J. Ehrhardt, A.S. Alabi, P.G. Kremsner, W. Rabsch, K. Becker, F.T. Foguim, T. Kuczius, M. Esen, F. Schaumburg. Bacterial contamination of water samples in Gabon, 2013. J. Microbiolol. Immunol. Infect. 2017 50(5):718-722
M. Herten, T. Bisdas, D. Knaack, K. Becker, N. Osada, G.B. Torsello, E.A. Idelevich. Rapid in vitro quantification of S. aureus biofilms on vascular graft surfaces. Front Microbiol. 2017;8:2333
M.H. Wilke, K. Becker, S. Kloss, S.M. Heimann, A. Goldmann, B. Weber, M.W. Pletz, P. Simon, C. Petrik. Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin - a retrospective analysis of medical charts and re-imbursement data of real-life patient populations. GMS Infect. Dis. 2017 5(Doc02):1-8
T. Goerge, M.B. Lorenz, S. van Alen, N.O. Hübner, K. Becker, R. Köck. MRSA colonization and infection among persons with occupational livestock exposure in Europe: Prevalence, preventive options and evidence. Vet. Microbiol. 2017 200:6-12
F. Schaumburg, R. Dieckmann, T. Schmidt-Bräkling, K. Becker, E.A. Idelevich. First description of an Anaerobiospirillum succiniciproducens prosthetic joint infection. New Microbes New Infect. 2017 18: 1-2
A.B. Schulze, B. Heptner, T. Kessler, B. Baumgarten, V. Stoica, R. Wiewrodt, V. Warneke, W. Hartmann, J. Wüllenweber, C. Schülke, M. Schäfers, D. Wilmes, K. Becker, L. H. Schmidt, A. H. Groll, W. E. Berdel. Progressive disseminated histoplasmosis presenting with hemophagocytic lymphohistiocytosis and multi-organ eosinophilic epithelioid cell granulomatosis in an immunocompetent patient: A case report and review of the literature. Eur. J. Haematol. 2017 99(1):91-100
M. Herten, E.A. Idelevich, S. Sielker, K. Becker, A.S. Scherzinger, N. Osada, G.B. Torsello, T. Bisdas. Vascular graft impregnation with antibiotics - influence of high concentrations of rifampin, vancomycin, daptomycin and bacteriophage endolysin HY-133 on viability of vascular cells. Med. Sci. Monit. Basic Res. 2017 23:250-257
U. Kaspar, A. Kriegeskorte, T. Schubert, G. Peters, C. Rudack, D.H. Pieper, M. Wos-Oxley, K. Becker. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ. Microbiol. 2016 18(7): 2130-42
R. Köck, P. Werner, A.W. Friedrich, C. Fegeler, K. Becker for the Prevalence of Multiresistant Microorganisms (PMM) Study Group. Persistence of nasal colonization with human pathogenic bacteria and associated antimicrobial resistance in the German general population. New Microbes New Infect. 2016 9:24-34
E.A. Idelevich, F. Schaumburg, D. Knaack, A.S. Scherzinger, W. Mutter, G. Peters, A. Peschel, K. Becker. The recombinant bacteriophage endolysin HY-133 exhibits in vitro activity against different African clonal lineages of the Staphylococcus aureus complex including Staphylococcus schweitzeri. Antimicrob. Agents Chemother. 2016 60(4):2551-3
K. Becker, O. Denis, S. Roisin, A. Mellmann, E.A. Idelevich, D. Knaack, S. van Alen, A. Kriegeskorte, R. Köck, F. Schaumburg, G. Peters, B. Ballhausen. Detection of mecA- and mecC-positive methicillin-resistant Staphylococcus aureus (MRSA) isolates by the new Xpert® MRSA Gen 3 PCR. J. Clin. Microbiol. 2016 54(1):180-4
F. Schaumburg, G. Peters, A. Alabi, K. Becker, E. Idelevich. Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 2016 71(1):41-4
F. Schaumburg, R. Köck, F. Leendertz, K. Becker. Airport door handles and the global spread of antimicrobial-resistant bacteria: a cross sectional study. Clin. Microbiol. Infect. 2016 22(12):1010-1011
Y. Reers, E.A. Idelevich, H. Pätkau, M.C. Sauerland, S. Tafelski, I. Nachtigall, W.E. Berdel, G. Peters, G. Silling, K. Becker for the Molecular Diagnostics of Sepsis Study Group. Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia. Diagn. Microbiol. Infect. Dis. 2016 85(4):413-5
A.F. Schmalreck, B. Willinger, E.A. Idelevich, C. Fegeler, C. Lass-Flörl, W. Fegeler, K. Becker. Parallel- and cross-resistances of clinical yeast isolates determined by susceptibility pattern analysis. GMS Infect. Dis. 2016 4(Doc02):1-13
M.L. Wos-Oxley, D. Chaves-Moreno, R. Jáuregui, A.P.A. Oxley, U. Kaspar, I. Plumeier, S. Kahl, C. Rudack, K. Becker, D.H. Pieper. Exploring the bacterial assemblages along the human nasal passage. Environ. Microbiol. 2016 18(7):2259-71
E.A. Idelevich, M. Büsing, A. Mischnik, M. Kaase, I. Bekeredjian-Ding, K. Becker. False non-susceptible results of tigecycline susceptibility testing against Enterobacteriaceae by an automated system: a multicentre study. J. Med. Microbiol. 2016 65(8):877-81
F. Schaumburg, F.C. Onwugamba, R. Akulenko, G. Peters, A. Mellmann, R. Köck, K. Becker. A geospatial analysis of flies and the spread of antimicrobial resistant bacteria. Int. J. Med. Microbiol. 2016 306(7):566-71
E.A. Idelevich, K. Becker, J. Schmitz, D. Knaack, G. Peters, R. Köck. Evaluation of an automated system for reading and interpreting disk diffusion antimicrobial susceptibility testing of fastidious bacteria. PLoS ONE 2016 11(7):e0159183
M. Kresken, B. Körber-Irrgang, C. Petrik, H. Seifert, A. Rodloff, K. Becker. Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006-2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST) GMS Infect. Dis. 2016 4(Doc07):1-17
M. Kaase, S. Schimanski,·R. Schiller, B. Beyreiß, A. Thürmer, J. Steinmann, V.A. Kempf, C. Hess, I. Sobottka, I. Fenner, S. Ziesing, I. Burckhardt, L. von Müller, A. Hamprecht, I. Tammer, N. Wantia, K. Becker, T. Holzmann, M. Furitsch, G. Volmer, S.G. Gatermann.·Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals. Int. J. Med. Microbiol. 2016 306(6):415-20
L.M. Koeth, P. Apfalter, K. Becker, G. Gesu, L. Martínez-Martínez, S.D. Lahiri, R.A. Alm, J. Ambler, J. Iaconis. Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus. Diagn. Microbiol. Infect. Dis. 2016 85(4):452-8
Idelevich, C. Lanckohr, D. Horn, L.H. Wieler, K. Becker, R. Köck. Antibiotika-resistente Erreger in Deutschland. Die Rolle von nicht nosokomialen Ansteckungsquellen. [Multidrug-resistant bacteria in Germany: The impact of sources outside healthcare facilities] Bundesgesundheitsbl. Gesundheitsforschung Gesundheitsschutz. 2016 59(1):113-23
E.A. Idelevich, K. Becker. Identification and susceptibility testing from shortly incubated cultures accelerate blood culture diagnostics at no cost. [letter] Clin. Infect. Dis. 2016 62(2):268-9
M. Pohlen, J. Marx, A. Mellmann, K. Becker, R.M. Mesters, J.H. Mikesch, C. Schliemann, G. Lenz, C. Müller-Tidow, T. Büchner, U. Krug, M. Stelljes, H. Karch, G. Peters, U. Gerth, D. Görlich, W.E. Berdel. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: Two parallel patient cohorts treated in a single center. Haematologica 2016 101(10):1208-15
D. Harmsen. Real-time genome sequencing of resistant bacteria provides precision infection control in an institutional setting. J. Clin. Microbiol. 2016 54(12):2874-81
S. Junge, D. Görlich, M. den Reijer, B. Wiedemann, B. Tümmler, H. Ellemunter, A. Dübbers, P. Küster, M. Ballmann, C. Koerner-Rettberg, J. Große-Onnebrink, E. Heuer, W. Sextro, J. G. Mainz, J. Hammermann, J. Riethmüller, U. Graepler-Mainka, D. Staab, B. Wollschläger, R. Szczepanski, A. Schuster, F. K. Tegtmeyer, S. Sutharsan, A. Wald, J. R. Nofer, W. van Wamel, K. Becker, G. Peters, B. C. Kahl. Factors associated with worse lung function in cystic fibrosis patients with persistent Staphylococcus aureus. PLoS One. 2016 11(11):e0166220
M. Hussain, T. Steinbacher, G. Peters, C. Heilmann, K. Becker. The adhesive properties of the Staphylococcus lugdunensis multifunctional autolysin AtlL and its role in biofilm formation and internalization. Int J Med Microbiol. 2015 305(1):129-139
E.A. Idelevich, G. Silling, Y. Niederbracht, H. Penner, M.C. Sauerland, S. Tafelski, I. Nachtigall, W.E. Berdel, G. Peters, K. Becker, Molecular Diagnostics of Sepsis study group. Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study. Med. Microbiol. Immunol. 2015 204(5):585-92
F. Schaumburg, B. Gast, H. Sannon, A. Mellmann, K. Becker. Is Africa the origin of major Haitian Staphylococcus aureus lineages? Int. J. Infect. Dis 2015 34:1-2
E.A. Idelevich, B. Grünastel, G. Peters, K. Becker. Direct blood culturing on solid medium outperforms automated continuously monitored broth-based blood culture system in terms of time to identification and susceptibility testing. New Microbes New Infect. 2015 10:19-24
N.A. Laham, J.R. Mediavilla, L. Chen, N. Abdelateef, F.A. Elamreen, C.C. Ginocchio, D. Pierard, K. Becker, B.N. Kreiswirth. MRSA clonal complex 22 strains harboring toxic shock syndrome toxin (TSST-1) are endemic in the primary hospital in Gaza, Palestine. PLoS One 2015 10(3):e0120008
F. Schaumburg, M. Pauly, E. Anoh, A. Mossoun, L. Wiersma, G. Schubert, A. Flammen, A.S. Alabi, J.J. Muyembe-Tamfum, M.P. Grobusch, S. Karhemere, C. Akoua-Koffi, E. Couacy-Hymann, P.G. Kremsner, A. Mellmann, K. Becker, F.H. Leendertz, G. Peters.Staphylococcus aureus complex from animals and humans in three remote African regions. Clin. Microbiol. Infect. 2015 21(4):345.e1-8
A. Kriegeskorte, N.I. Lorè, A. Bragonzi, C. Riva, M. Kelkenberg, K. Becker, R.A. Proctor, G. Peters, B.C. Kahl. Thymidine-dependent Staphylococcus aureus small colony variants (SCVs) are induced by trimethoprim-sulfamethoxazole (SXT) and have an increased fitness during SXT challenge. Antimicrob. Agents Chemother. 2015 59(12):7265-72
C. Kraef, A.S. Alabi, G. Peters, K. Becker, P.G. Kremsner, E. Rossatanga, A. Mellmann, M.P. Grobusch, P. Zanger, F. Schaumburg. Co-detection of Panton-Valentine leukocidin encoding genes and cotrimoxazole resistance in Staphylococcus aureus in Gabon: implications for HIV-patients' care. Front. Microbiol. 2015 6:60
N.B. Rajendran, J. Eikmeier, K. Becker, M. Hussain, G. Peters, C. Heilmann. Important contribution of the novel locus comEB to extracellular DNA-dependent Staphylococcus lugdunensis biofilm formation. Infect. Immun. 2015 83(12):4682-92
L.M. Strauß, C. Dahms, K. Becker, A. Kramer, M. Kaase, A. Mellmann. Development and evaluation of a novel universal β-lactamase gene subtyping assay for blaSHV, blaTEM and blaCTX-M using clinical and livestock-associated Escherichia coli. J. Antimicrob. Chemother. 2015 70(3):710-5
F. Schaumburg, A.S. Alabi, H. Kaba, B. Lell, K. Becker, M.P. Grobusch, P.G. Kremsner, A. Mellmann. Molecular characterization of Shigella spp. from patients in Gabon 2011-2013. Trans. R. Soc. Trop. Med. Hyg. 2015 109(4):275-9
K. Kerl, K. Ehlert, A. Brentrup, M. Schiborr, K. Keyvani, K. Becker, C. Rossig, A.H. Groll. Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T-lymphocyte recovery. Transpl. Infect. Dis. 2015 17(1):119-24
S. Tafelski, I. Nachtigall, T. Adam, S. Bereswill, J. Faust, A. Tamarkin, T. Trefzer, M. Deja, E.A. Idelevich, K.D. Wernecke, K. Becker, C. Spies for the Molecular Diagnostics of Sepsis Study Group. Molecular Diagnostics of Sepsis Study Group. Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis. J Int Med Res. 2015 43(3):364-77
C. Berning, C. Lanckohr, H. Baumgartner, M. Drescher, K. Becker, G. Peters, R. Köck, B.C. Kahl. Fatal infections caused by methicillin-resistant Staphylococcus aureus of clonal complex 398: case presentations and molecular epidemiology. JMM Case Reports 2015 2(2):1-4
J. Ehrhardt, A.S. Alabi, T. Kuczius, F.F. Tsombeng, K. Becker, P.G. Kremsner, F. Schaumburg, M. Esen. Population structure of Legionella spp. from environmental samples in Gabon, 2013. Infect. Genet. Evol. 2015 33:299-303
O.O. Ayepola, N.A. Olasupo, L.O. Egwari, K. Becker, F. Schaumburg. Molecular characterization and antimicrobial susceptibility of Staphylococcus aureus strains from clinical infection and asymptomatic carriers in Southwest Nigeria. PLoS ONE 2015 10(9):e0137531
M. Grinholc, A. Rodziewicz, K. Forys, A. Rapacka-Zdonczyk, A. Kawiak, A. Domachowska, G. Golunski, C. Wolz, L. Mesak, K. Becker, K.P. Bielawski. Fine-tuning recA expression in Staphylococcus aureus for antimicrobial photoinactivation: importance of photo-induced DNA damage in the photoinactivation mechanism. Appl. Microbiol. Biotechnol. 2015 99(21):9161-76
B. Ballhausen, A. Kriegeskorte, N. Schleimer, G. Peters, K. Becker. The mecA homolog mecC confers resistance against beta-lactams in Staphylococcus aureus irrespective of the genetic strain background. Antimicrob. Agents Chemother. 2014 58(7):3791-8
E.A. Idelevich, I. Schüle, B. Grünastel, J. Wüllenweber, G. Peters, K. Becker. Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin. Microbiol. Infect. 2014 20(10):1001-6
B. Ballhausen*, P. Jung*, A. Kriegeskorte, P.E. Makgotlho, U. Ruffing, L. von Müller, R. Köck, G. Peters, M. Herrmann, W. Ziebuhr, K. Becker*, M. Bischoff* (*contributed equally). LA-MRSA CC398 differ from classical community acquired-MRSA and hospital acquired-MRSA lineages: Functional analysis of infection and colonization processes. Int. J. Med. Microbiol. 2014 304(7):777-86
E.A. Idelevich, I. Schüle, B. Grünastel, J. Wüllenweber, G. Peters, K. Becker. Acceleration of antimicrobial susceptibility esting from positive blood cultures by inoculation of shortly incubated solid medium ultures into Vitek 2. J. Clin. Microbiol. 2014 52(11):4058-62
F. Schaumburg, E.A. Idelevich, G. Peters, A. Mellmann, C. von Eiff, K. Becker and Study Group. Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004-2011). Clin. Microbiol. Infect. 2014 20(9):O554-7
E.A. Idelevich, T. Walther, S. Molinaro, X. Li, G. Xia, A. Wieser, G. Peters, A. Peschel, K. Becker. Bacteriophage-based latex agglutination test for rapid identification of Staphylococcus aureus. J. Clin. Microbiol. 2014 52(9):3394-8
A. Kriegeskorte, S. Grubmüller, C. Huber, B.C. Kahl, C. von Eiff, R.A. Proctor, G. Peters, W. Eisenreich, K. Becker.Staphylococcus aureus small colony variants show common metabolic features in central metabolism irrespective of the underlying auxotrophism. Front. Cell. Infect. Microbiol. 2014 4:141
F. Schaumburg, M. Pauly, G. Schubert, A. Shittu, S. Tong, F. Leendertz, G. Peters, K. Becker. Characterization of a novel thermostable nuclease homolog (NucM) in a highly divergent Staphylococcus aureus clade. J. Clin. Microbiol. 2014 52(11):4036-8
R. Gläser, K. Becker, C. von Eiff, U. Meyer-Hoffert, J. Harder. Decreased susceptibility of Staphylococcus aureus small colony variants (SCVs) towards human antimicrobial peptides. J. Invest. Dermatol. 2014 134(9):2347-50
A. Kriegeskorte, D. Block, M. Drescher, N. Windmüller, A. Mellmann, C. Baum, C. Neumann, N.I. Lorè, A. Bragonzi, E Liebau, P. Hertel, J. Seggewiss, K. Becker, R.A. Proctor, G. Peters, B.C. Kahl. Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression. MBio. 2014 5(4): pii: e01447-14
F. Schaumburg, A. Alabi, G. Mombo-Ngoma, H. Kaba, R. Zoleko, D. Diop, J.R. Mackanga, A. Basra, R. Gonzalez, C. Menendez, M. Grobusch, P. Kremsner, R. Köck, G. Peters, M. Ramharter, K. Becker. Transmission of Staphylococcus aureus between mothers and infants in an African setting. Clin. Microbiol. Infect. 2014 20(6):O390-6
A. Camarinha-Silva, R. Jáuregui, D. Chaves-Moreno, A.P. Oxley, F. Schaumburg, K. Becker, M.L. Wos-Oxley, D.H. Pieper. Comparing the anterior nare bacterial community of two discrete human populations using Illumina amplicon sequencing. Environ. Microbiol. 2014 16(9):2939-52
E.A. Idelevich, C.M. Grunewald, J. Wüllenweber, K. Becker. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2. PLoS ONE 9(12):e114834
K.O. Okon, A.O. Shittu, A.A. Kudi, H. Umar, K. Becker, F. Schaumburg F. Population dynamics of Staphylococcus aureus from Northeastern Nigeria in 2007 and 2012. Epidemiol. Infect. 2014 142(8):1737-40
F. Schaumburg, A.S. Alabi, L. Frielinghaus, M.P. Grobusch, R. Köck, K. Becker, S. Issifou, P.G. Kremsner, G. Peters, A. Mellmann. The risk to import ESBL-producing Enterobacteriaceae and Staphylococcus aureus through chicken meat trade in Gabon. BMC Microbiol. 14(1):286
A.F. Schmalreck, M. Lackner, K. Becker, W. Fegeler, V. Czaika, H. Ulmer, C. Lass-Flörl. Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts. Antimicrob. Agents Chemother. 2014 58(3):1575-85
R. Dieckmann, D. Schulz, G. Gosheger, K. Becker, K. Daniilidis, A. Streitbürger, J. Hardes, S. Hoell. Two-stage hip revision arthroplasty with a hexagonal modular cementless stem in cases of periprosthetic infection. BMC Musculoskelet. Disord. 2014 15:398
M. Alnawaiseh, M.R. Böhm, E.A. Idelevich, K. Becker, S. Grewe, N. Eter, U.H. Grenzebach, N. Eter. Erfolgreiche Therapie einer Fusarium-assoziierten Keratitis bei multiresistentem Keim und multimorbidem Patienten. Ophthalmologe 2014 111(3):259-61
Czaika V, Nenoff P, Glöckner A, Becker K, Fegeler W, Schmalreck AF. Detection of azole susceptibility patterns in clinical yeast strains isolated from 1998 to 2008. New Microbiol. 2014 37(4):465-94
A.F. Schmalreck, W. Fegeler, K. Becker, C. Lass-Flörl, V. Czaika. Cross-resistance of azoles, echinocandins, flucytosine, and amphotericin B in clinically important hyphomycetes. Int. J. Microbiol. Res. 6(1): 519-44
A.F. Schmalreck, H. Hof, K. Becker, W. Fegeler, V. Czaika. Susceptibility patterns and cross-resistance of: antimicrobial peptides (defensins, bacteriocins, ionophores), aminoglycosides, macrolides, penicillins, cephalosporins, and carbapenems in Listeria spp. World Res. J. Antimicrob. Agents 2014 3(1):39-61
A. Domhöver, R. Köck, K. Becker, A. Mellmann, A.W. Friedrich. Prävalenz von Methicillin-resistenten Staphylococcus aureus (MRSA) und mit MRSA-assoziierte Risikofaktoren in der ambulanten Pflege. Umweltmed. Hyg. Arbeitsmed. 2014 19(5) 426-430
R. Köck, L. Eißing, M. Boschin, B. Ellger, D. Horn, E. Idelevich, K. Becker. Evaluation of Bactec™ Mycosis IC/F and Plus Aerobic/F blood culture bottles for the detection of Candida in the presence of antifungal agents. J. Clin. Microbiol. 51(11):3683-7
K. Becker, A.R. Larsen, R.L. Skov, G.K. Paterson, M.A. Holmes, A.J. Sabat, A.W.. Friedrich, R. Köck, G. Peters, A. Kriegeskorte. Evaluation of a modular multiplex-PCR methicillin-resistant Staphylococcus aureus (MRSA) detection assay adapted for mecC detection. J. Clin. Microbiol. 2013 51(6):1917-9
D.O. Kolawole, A. Adeyanju, F. Schaumburg, A.L. Akinyoola, O.O. Lawal, Y.B. Amusa, R. Köck, K. Becker. Characterization of colonizing Staphylococcus aureus isolated from surgical wards' patients in a Nigerian university hospital. PLoS ONE 2013 8(7): e68721
F. Schaumburg, C. Schmalstieg, B. Fiedler, A. Brentrup, H. Omran, K. Becker. A bumpy road to diagnosis of a Kytococcus schroeteri shunt infection. J Med Microbiol. 2013 62(1):165-8
A. Jurke, R. Köck, K. Becker, S. Thole, R. Hendrix, J. Rossen, I. Daniels-Haardt, A.W. Friedrich. Molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA): think regionally but use globally uniform typing languages. Euro Surveill. 2013;18(43):pii=20617
A. Jurke, R. Köck, K. Becker, S. Thole, R. Hendrix, J. Rossen, I. Daniels-Haardt, A.W. Friedrich. Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011. Euro Surveill. 2013 18(36):pii=20579
F. Schaumburg, L. Mugisha, P. Kappeller, C. Fichtel, R. Köck, S. Köndgen, K. Becker, C. Boesch, G. Peters, F. Leendertz. Evaluation of non-invasive biological samples to monitor Staphylococcus aureus colonization in great apes and lemurs. PLoS ONE 2013 8(10):e78046
A.G. Al-Bakri, H. Al-Hadithi, V. Kasabri, G. Othman, A. Kriegeskorte, K. Becker. The epidemiology and molecular characterization of methicillin-resistant staphylococci sampled from a healthy Jordanian population. Epidemiol. Infect. 2013 141(11):2384-91
A.J. Sabat, R. Köck, V. Akkerboom, R. Hendrix, R.L. Skov, K. Becker, A.W. Friedrich. Novel organization of arginine catabolic mobile element and staphylococcal cassette chromosome mec composite island and its horizontal transfer between distinct Staphylococcus aureus genotypes. Antimicrob. Agents Chemother. 2013 57(11):5774-7
C. Fehrmann, K. Jurk, A. Bertling, G. Seidel, W. Fegeler, B.E. Kehrel, G. Peters, K. Becker, C. Heilmann. Role for the fibrinogen-binding proteins Coagulase and Efb in the Staphylococcus aureus-Candida interaction. Int. J. Med. Microbiol. 2013 303(5):230-8
A.A. Shehabi, R. Abu-Yousef, E. Badran, A.G. Al-Bakri, L.F. Abu-Qatouseh, K. Becker. Major characteristics of Staphylococcus aureus colonizing Jordanian infants. Pediatr Int. 2013 55(3):300-4
F. Schaumburg, A. Alabi, C. Kokou, M.P. Grobusch, R. Köck, H. Kaba, K. Becker, A.A. Adegnika, P. Kremsner, G. Peters, A. Mellmann. High burden of extended-spectrum -lactamase-producing Enterobacteriaceae in Gabon. J Antimicrob Chemother. 2013 68(9):2140-3
K.M Brandt; A. Mellmann; B. Ballhausen; C. Jenke; P.J. van der Wolf; E.M. Broens; K. Becker; R. Köck. Evaluation of multiple-locus variable number of tandem repeats analysis for typing livestock-associated methicillin-resistant Staphylococcus aureus. PLoS ONE 2013 8(1):e54425
R. Köck, F. Schaumburg, A. Mellmann, M. Köksal, A. Jurke, K. Becker; A. W. Friedrich. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS ONE 2013 8(2): e55040
E.A. Idelevich, C.A. Pogoda, B. Ballhausen, J. Wüllenweber1, L. Eckardt, H. Baumgartner, J. Waltenberger, G. Peters, K. Becker. Pacemaker lead infection and related bacteremia caused by normal and small colony variant phenotypes of Bacillus licheniformis. J. Med. Microbiol. 2013 62(6) 940-4
V. Czaika, P. Nenoff, A. Glöckner, K. Becker, W. Fegeler and A.F. Schmalreck. Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics. Int. J. Microbiol. 2013:703905
D. Bettenworth, T.M. Nowacki, A. Friedrich, K. Becker, J. Wessling, J. Heidemann. Crohn's disease complicated by intestinal infection with methicillin-resistant Staphylococcus aureus.World J. Gastroenterol. 2013 19(27): 4418-4421
A. Kriegeskorte, B. Ballhausen, E. A. Idelevich, R. Köck, A.W. Friedrich, H. Karch, G. Peters, K. Becker. Human MRSA isolates with novel genetic homolog, Germany. Emerg. Infect. Dis. 2012 18(6) 1016-8
F. Schaumburg, R. Köck, A. Mellmann, L. Richer, F. Hasenberg, A. Kriegeskorte, A.W. Friedrich, S. Gatermann, G. Peters, K. Becker and Study Group. Population dynamics among methicillin resistant Staphylococcus aureus in Germany during a 6-year period. J. Clin. Microbiol. 2012 50(10):3186-92
A.J. Sabat, M. Koksal, V. Akkerboom, S. Monecke, A. Kriegeskorte, R. Hendrix, R. Ehricht, R. Köck, K. Becker, A.W. Friedrich. Detection of new methicillin-resistant Staphylococcus aureus that carry novel genetic homologue and important virulence determinants. J. Clin. Microbiol. 2012 50(10):3374-77
D.S. Smyth, J.M. Kafer, G.A. Wasserman, L. Velickovic, B. Mathema, R.S. Holzman, T.A. Knipe, K. Becker, C. von Eiff, G. Peters, L. Chen, B.N. Kreiswirth, R.P. Novick, B. Shopsin. Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremia. J. Infect. Dis. 2012 206(8):1168-77
A.F. Schmalreck, B. Willinger, G. Haase, G. Blum, C. Lass-Flörl, W. Fegeler, K. Becker for the Antifungal Susceptibility Testing (AFST) Study Group. Species and susceptibility distribution of 1,062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses 2012 55(3) e124-e137
A. Schmalreck, B. Willinger, V. Czaika, W. Fegeler, K. Becker, G. Blum, C. Lass-Flörl. Susceptibility screening of hyphae-forming fungi with a new, easy, and fast inoculum preparation method. Mycopathologia 2012 174(5-6):467-74
L.G. Garcia, S. Lemaire, B.C. Kahl, K. Becker, R.A. Proctor, P.M. Tulkens, F. Van Bambeke. Intracellular forms of menadione-dependent small-colony variants of methicillin-resistant Staphylococcus aureus are hypersusceptible to ß-lactams in a THP-1 cell model due to cooperation between vacuolar acidic pH and oxidant species. J. Antimicrob. Chemother. 2012 67(12):2873-81
L.G. Garcia, S. Lemaire, B.C. Kahl, K. Becker, R.A. Proctor, P.M. Tulkens, F. Van Bambeke. Influence of the protein kinase C activator, phorbol myristate acetate (PMA), on the intracellular activity of antibiotics against hemin and menadione auxotrophic small-colony variant (SCV) mutants of Staphylococcus aureus and their wild-type parental strain in human THP-1 cells. Antimicrob. Agents Chemother. 2012 56(12):6166-74
F. Schaumburg, B. Biallas, A.S. Alabi, M.P. Grobusch, E.N. Feugap, B. Lell, A. Mellmann, G. Peters, P.G. Kremsner, K. Becker, A.A. Adegnika. Clonal structure of Staphylococcus aureus colonizing children with sickle cell anaemia and healthy controls. Epidemiol. Infect. 2012 [Epub ahead of print]
F. Schaumburg, A. S. Alabi, R. Köck, A. Mellmann, P. G. Kremsner, C. Boesch, K. Becker, F. H. Leendertz, G. Peters. Highly divergent Staphylococcus aureus isolates from African non-human primates. Environ. Microbiol. Rep. 2012 4(1):141-46
B. Köten, K. Becker, R. Podschun, C. von Eiff, U. Meyer-Hoffert, J. Harder, R. Gläser. Susceptibility of Staphylococcus aureus bacteremia strains to different skin-derived antimicrobial proteins. Arch Dermatol Res. 2012 304(8):633-7
F. Schaumburg, L. Mugisha, B. Peck, K. Becker, T.R. Gillespie, G. Peters, F.H. Leendertz. Drug-resistant human Staphylococcus aureus in sanctuary apes pose a threat to endangered wild ape populations. Am. J. Primatol. 2012 74(12):1071-5
T. Kuczius, K. Becker, A. Fischer, W. Zhang. Simultaneous detection of three CNS indicator proteins in complex suspensions using a single immuno-PCR protocol. Anal Biochem. 2012 431(1):4-10
U. Ateba Ngoa, F. Schaumburg, A.A. Adegnika, K. Kösters, T. Möller, J.F. Fernandes, A. Alabi, S. Issifou, K. Becker, M.P. Grobusch, P.G. Kremsner, B. Lell. Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa. Acta Trop. 2012 124(1):42-7
A. Camarinha-Silva, M.L. Wos-Oxley, R. Jáuregui, K. Becker, D.H. Pieper. Validating T-RFLP as a sensitive and high-throughput approach to assess bacterial diversity patterns in human anterior nares. FEMS Microbiol. Ecol. 2012 79 (1) 98-108
G. Sander, T. Börner, A. Kriegeskorte, C. von Eiff, K. Becker, and E. Mahabir-Brenner. Catheter colonization and abscess formation due to Staphylococcus epidermidis with normal and small-colony-variant phenotype is mouse strain dependent. PLoS One. 2012 7(5):e36602
A. Garofalo, C. Giai, S. Lattar, N. Gardella, M. Mollerach, B.C. Kahl, K. Becker, A. Prince, D. Sordelli, M. Gómez. The length of the Staphylococcus aureus protein A polymorphic region regulates inflammation: Impact on acute and chronic infection. J. Infect. Dis. 2012 206(1):81-90
L. Garcia, S. Lemaire, B. Kahl, K. Becker, R. Proctor, O. Denis, P. Tulkens, F. Van Bambeke. Pharmacodynamic Evaluation of the activity of antibiotics against hemin and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob. Agents Chemother. 2012 56 (7) 3700-11
G.A. Khayrullina, C.A. Raabe, C.H. Hoe, K. Becker, R. Reinhardt, T.H. Tang, T.S. Rozhdestvensky, A.M. Kopylov. Transcription analysis and small non-protein coding RNAs associated with bacterial ribosomal protein operons. Curr Med Chem. 2012 19(30):5187-98
D. Moissenet, K. Becker, A. Mérens, A. Ferroni, B. Dubern, H. Vu-Thien. Persistent blood stream infection with Kocuria rhizophila related to a damaged central catheter. J. Clin. Microbiol. 2012 50(4) 1495-1498
S.M. Lattar, L.P. Tuchscherr, D. Centrón, K. Becker, S.C. Predari, F.R. Buzzola, D.A. Robinson, D.O. Sordelli. Molecular fingerprinting of Staphylococcus aureus isolated from patients with osteomyelitis in Argentina and clonal distribution of the cap5(8) genes and of other selected virulence genes Eur J Clin Microbiol Infect Dis 2012 31(10):2559-2566
M. Elazhari, L.F Abu-Quatouseh, D. Elhabchi, K. Zerouali, N. Dersi, R. Saile, M. Timinouni, K. Becker. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco). Int. J. Med. Microbiol. 2012 302 (2) 96-100
<//li><//li><//li><//li><//li><//li><//li><//li><//li><//li>
A. Kriegeskorte, S. König, G. Sander, A. Pirkl, E. Mahabir, R.A. Proctor, C. von Eiff, G. Peters, K. Becker. Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 2011 11(12) 2476-2490
E.A. Idelevich, C. von Eiff, A.W. Friedrich, D. Iannelli, G. Xia, G. Peters, A. Peschel, I. Wanninger, K. Becker. In vitro activity of a novel antimicrobial agent PRF-119 - a recombinant chimeric bacteriophage endolysin against Staphylococcus aureus. Antimicrob. Agents Chemother. 2011 55(9) 4416-4419
F. Schaumburg, U.A. Ngoa, K. Kösters, R. Köck, A.A. Adegnika, P.G. Kremsner, B. Lell, G. Peters, A. Mellmann, K. Becker. Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon. Clin Microbiol Infect. 2011 17(10) 1507-1513
E.A. Idelevich, A. Kriegeskorte, W. Stubbings, B. Kahl, G. Peters, K. Becker. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes. J. Antimicrob. Chemother. 2011 66(12) 2809-2813
R. Köck, K. Siam, S. Al-Malat, J. Christmann, F. Schaumburg, K. Becker, A.W. Friedrich. Characteristics of hospital patients colonized with livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) CC398 versus other MRSA clones. J. Hosp. Infect. 2011 79(4) 292-296
F. Schaumburg, R. Köck, A.W. Friedrich, S. Soulanoudjingar, U.A. Ngoa, C. von Eiff, S. Issifou, P.G. Kremsner, M. Herrmann, G. Peters, K. Becker. Population Structure of Staphylococcus aureus from Remote African Babongo Pygmies. PLoS Negl. Trop. Dis. 2011 5(5) 2011 e1150
L. Tuchscherr, E. Medina, M. Hussain, W. Völker, V. Heitmann, S. Niemann, D. Holzinger, J. Roth, R.A. Proctor, K. Becker, G. Peters, B. Löffler. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol. Med. 3 (3) 2011 129-141
M. Kresken, K. Becker, H. Seifert, E. Leitner, B. Körber-Irrgang, C. von Eiff, P.A. Löschmann and Study Group. Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms including multidrug-resistant pathogens in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 30 (9) 2011 1095-1103
M.S. Barbagelata, L. Alvarez, M. Gordiola, L. Tuchscherr, C. von Eiff, K. Becker, D.O. Sordelli, F.R. Buzzola. Auxotrophic mutant of Staphylococcus aureus interferes with nasal colonization by the wild type. Microbes Infect. 2011 13(12-13) 1081-1090
F. Sachse, K. Becker, T.J. Basel, D. Weiss, C. Rudack. IKK-2 inhibitor TPCA-1 represses nasal epithelial inflammation in vitro. Rhinology. 2011 49(2):168-73
N. Nippe, G. Varga, D. Holzinger, B. Löffler, E. Medina, K. Becker, J. Roth, J.M. Ehrchen, C. Sunderkötter. Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response. J Invest Dermatol. 131 (1) 2011 125-132
L.F. Abu-Qatouseh, S.V. Chinni, J. Seggewiß, R.A. Proctor, J. Brosius, T.S. Rozhdestvensky, G. Peters, C. von Eiff, K. Becker. Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J. Mol. Med. 88 (6) 2010 565-575
L. Tuchscherr, V. Heitmann, M. Hussain, D. Viemann, J. Roth, C. von Eiff, G. Peters, K. Becker, B. Löffler. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J. Infect. Dis. 202 (7) 2010 1031-1040
M. L. Wos-Oxley, I. Plumeier, C. von Eiff, S. Taudien, M. Platzer, R. Vilchez-Vargas, K. Becker, D. H. Pieper. A poke into the diversity and associations within human anterior nare microbial communities. ISME J. 4 (7) 2010 839-851
F. Sachse, K. Becker, C. von Eiff, D. Metze, C. Rudack. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 65 (11) 2010 1430-1437
M. Grundmeier, L. Tuchscherr, M. Brück, D. Viemann, J. Roth, E. Willscher, K. Becker, G. Peters, B. Löffler. Staphylococcal strains vary greatly in their ability to induce an inflammatory response in endothelial cells. J. Infect. Dis. 201 (6) 2010 871-880
F. Szabados, K. Becker, C. von Eiff, M. Kaase, S. Gatermann. The matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302Da are not associated with the presence of Panton-Valentine leukocidin. Int. J. Med. Microbiol. 2010 [Epub ahead of print]
N. Werth, C. Beerlage, C. Rosenberger, A.S. Yazdi, M. Edelmann, A. Amr, W. Bernhardt, C. von Eiff, K. Becker, A. Schäfer, A. Peschel, V.A. Kempf. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 5 (7) 2010 e11576
R. Capparelli, N. Nocerino, R. Lanzetta, A. Silipo, A. Amoresano, C. Giangrande, K. Becker, G. Blaiotta, A. Evidente, A. Cimmino, M. Iannaccone, M. Parlato, C. Medaglia, S. Roperto, F. Roperto, L. Ramunno, D. Iannelli. Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice. PLoS ONE 5 (7) 2010 e11720
S. Böcher, B. Middendorf, H. Westh, A. Mellmann, K. Becker, R. L. Skov, A. Friedrich. Semi-selective broth improves screening for methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. J. Antimicrob. Chemother. 65 (4) 2010 717-720
H. F. Bloos, F. Hinder, K. Becker, S. Sachse, A. Mekontso-Dessap, E. Straube, V. Cattoir, C. Brun-Buisson, K. Reinhart, G. Peters, M. Bauer. A multicentre trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med. 36 (2) 2010 241-247
F. Sachse, K. Becker, C. Rudack. Incidence of staphylococcal colonization and of the 753Q Toll-like receptor 2 variant in nasal polyposis. Am. J. Rhinol. Allergy 24 (1) 2010 e10-e13
H. Grundmann, D.M. Aanensen, C.C. van den Wijngaard, B.G. Spratt, D. Harmsen, A.W. Friedrich, the European Staphylococcal Reference Laboratory Working Group (... K. Becker...). Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: A molecular-epidemiological analysis. PLoS Med. 7(1) 2010 e1000215
U. Reischl, J. Frick, S. Hoermansdorfer, H. Melzl, M. Bollwein, H. J. Linde, K. Becker, R. Köck, C. Tuschak, U. Busch, A. Sing. Single-nucleotide polymorphism in the SCCmec-orfX junction distinguishes between livestock-associated MRSA CC398 and human epidemic MRSA strains. Euro.Surveill. 2009 14:pii: 19436
C. Rudack, F. Sachse, N. Albert, K. Becker, C. von Eiff. Immunomodulation of nasal epithelial cells by Staphylococcus aureus-derived serine proteases. J. Immunol. 183 (11) 2009 7592-7601
S.M. Lattar, L.P. Tuchscherr, R.L. Caccuri, D. Centrón, K. Becker, C.A. Alonso, C. Barberis, G. Miranda, F.R. Buzzola, C. von Eiff, D.O. Sordelli. Capsule expression and genotypic differences among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis. Infect. Immun. 77 (5) 2009 1968-1975
I. Joost, D. Blass, M. Burian, C. Goerke, C. Wolz, L. von Müller, K. Becker, K. Preissner, M. Herrmann, M. Bischoff. Transcription analysis of the extracellular adherence protein from Staphylococcus aureus in the authentic human infection and in vitro. J. Infect. Dis. 199 (10) 2009 1471-1478
R. Köck, J. Harlizius, N. Bressan, R. Laerberg, L.H. Wieler, W. Witte, R.H. Deurenberg, A. Voss, K. Becker, A.W. Friedrich. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 28 (11) 2009 1375-1382
C. Karsten, S. Baumgarte, A.W. Friedrich, C. von Eiff, K. Becker, W. Wosniok, A. Ammon, J. Bockemühl, H. Karch, H.I. Huppertz. Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur. J. Clin. Microbiol. Infect. Dis. 28 (8) 2009 935-943
R. Diller, U. Stratmann, E. Minin, C. von Eiff, G. Bäumer, H. Huismans, T. Helmschmied, K. Becker, H.U. Spiegel. ATIII attenuates endotoxemia induced healing impairment in the colon. J. Surg. Res. 157 (1) 2009 4-13
R. Köck, L. Brakensiek, A. Mellmann, F. Kipp, M. Henderikx, D. Harmsen, I. Daniels-Haardt, C. von Eiff, K. Becker, M.G. Hendrix, A.W. Friedrich. Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J. Hosp. Infect. 71 (4) 2009 320-326
D. Campoccia, L. Montanaro, C. von Eiff, V. Pirini, S. Ravaioli, K. Becker, C.R. Arciola. Cluster analysis of ribotyping profiles of Staphylococcus epidermidis isolates recovered from foreign body-associated orthopedic infections. J. Biomed. Mater. Res. A 88 (3) 2009 664-672
T. Kuczius, K. Becker, H. Karch, W. Zhang. High sensitivity detection of the glial fibrillary acidic protein as indicator for TSE risk material in meat products using an immuno-PCR. Mol. Nutr. Food Res. 53 (10) 2009 1329-1335
J. Lannergård, C. von Eiff, G. Sander, T. Cordes, J. Seggewiß, G. Peters, R.A. Proctor, K. Becker, D. Hughes. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 52 (11) 2008 4017-4022
K. Becker, F. Rutsch, A. Uekötter, F. Kipp, J. König, T. Marquardt, G. Peters, C. von Eiff. Kocuria rhizophila adds to the emerging spectrum of micrococcal species involved in human infections. J. Clin. Microbiol. 46 (10) 2008 3537-3539
F. Sachse, C. von Eiff, K. Becker, C. Rudack. Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. J. Inflamm. (Lond.) 5 (11) 2008 doi:10.1186/1476-9255-5-11
M. Hussain, C. von Eiff, B. Sinha, I. Joost, M. Herrmann, G. Peters, K. Becker. eap gene as novel target for specific identification of Staphylococcus aureus. J. Clin. Microbiol. 46 (2) 2008 470-476
I. Daniels-Haardt, A. Jurke, R. Köck, K. Becker, A.W. Friedrich. Der Einfluss regionaler Netzwerkbildung auf die Zusammenarbeit von Gesundheitsbehörden und Krankenhäusern. Strukturierte Erhebung und Weiterleitung von MRSA-Basiskennzahlen. Epidemiol. Bull. 2008 (28) 2008 219-223
W. Zhang, M. Bielaszewska, M. Pulz, K. Becker, A.W. Friedrich, H. Karch, T. Kuczius. A new immuno-PCR assay for the detection of low concentrations of Shiga toxin 2 and its variants. J. Clin. Microbiol. 46 (4) 2008 1292-1297
F. Sachse, C. von Eiff, K. Becker, M. Steinhoff, C. Rudack. Proinflammatory impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-alpha responses in primary human nasal epithelial cells. Int. Arch. Allergy Immunol. 145 (1) 2008 24-32
C. Schulze, A. Kroll, C.-M. Lehr, U.F. Schäfer, K. Becker, J. Schnekenburger, C. Schulze Isfort, R. Landsiedel, W. Wohlleben. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicol. 2 (2) 2008 51-61
C. von Eiff, D. Maas, G. Sander, A.W. Friedrich, G. Peters, K. Becker. Microbiological evaluation of a new growth-based approach for rapid detection of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 61 (6) 2008 1277-1280
A. Fischer, C. von Eiff, T. Kuczius, K. Omoe, G. Peters, K. Becker. A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins. J. Mol. Med. 85 (5) 2007 461-469
K. Becker, A. S. Almasri, C. von Eiff, G. Peters, C. Heilmann, W. Fegeler. Systematic Survey of Nonspecific Agglutination by Candida spp. in Latex Assays. J. Clin. Microbiol. 45 (4) 2007 1315-1318
C. Werbick, K. Becker, A. Mellmann, K.M. Juuti, C. von Eiff, G. Peters, P.I. Kuusela, A. Friedrich, B. Sinha. Staphylococcal chromosomal cassette mec type I, spa type, and expression of Pls are determinants of reduced cellular invasiveness of methicillin-resistant Staphylococcus aureus isolates. J. Infect. Dis. 195 (11) 2007 1678-1685
N. Al Laham, , H. Rohde, G. Sander, A. Fischer, M. Hussain, C. Heilmann, D. Mack, R. Proctor, G. Peters, K. Becker, C. von Eiff. Augmented expression of polysaccharide intercellular adhesin in a defined Staphylococcus epidermidis mutant with the small-colony-variant phenotype. J. Bacteriol. 189 (12) 2007 4494-4501
K. Trülzsch, B. Grabein, P. Schumann, A. Mellmann, U. Antonenka, J. Heesemann, K. Becker. Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens. Int. J. Syst. Evol. Microbiol. 57 (7) 2007 1543-1548
C. von Eiff, K.L. Taylor, A. Mellmann, A.I. Fattom, A.W. Friedrich, G. Peters, K. Becker. Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 58 (3) 2007 297-302
F. Bottner, A. Wegner, W. Winkelmann, K. Becker, M. Erren, C. Götze. Interleukin-6, procalcitonin and TNF-Alpha: Markers of peri-prosthetic infection following total joint replacement. J. Bone Joint Surg. Br. 89-B (1) 2007 94-99
T. Kaiser, J. Langhorst, H. Wittkowski , K. Becker, A.W. Friedrich, A. Rueffer, G.J. Dobos, J. Roth, D. Foell. Fecal S100A12 as non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56 (12) 2007 1706-1713
C. Rudack, M. Steinhoff, F. Mooren, K. Becker, C. von Eiff, F. Sachse. PAR-2 activation regulates IL-8 and GRO-Alpha synthesis by NF-kB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin. Exp. Allergy 37 (7) 2007 1009-1022
C.R. Arciola, L. Baldassarri, C. von Eiff, D. Campoccia, S. Ravaioli, V. Pirini, K. Becker, L. Montanaro. Prevalence of genes encoding for staphylococcal leukocidal toxins among clinical isolates of Staphylococcus aureus from implant orthopedic infections. Int. J. Artif. Organs 30 (9) 2007 792-797
J.-H. Mikesch, A. Rudat, M. Zühlsdorf, W.E. Berdel, R. Mesters, B. Conrad, K. Becker, W. Fegeler, C. Anthoni. Subcutaneous zygomycosis in neutropenia. J. Clin. Oncol. 25 (30) 2007 4844-4845
A.W. Friedrich, I. Daniels-Haardt, J.E.W.C. van Gemert-Pijnen, M.G.R. Hendrix, C. von Eiff, F. Kipp, K. Becker, R. Köck, F. Verhoeven, A. Mellmann. Ein regionales Netzwerk zur Prävention und Kontrolle von Infektionen durch MRSA: EUREGIO MRSA-net Twente/Münsterland. Epidemiol. Bull. (33) 2007 307-311 (Abdruck auch in: Hyg. Med. 32 (9) 2007 353–356)
I. Hörnig-Franz, B. C. Kahl, W. Tebbe, C. Kersting, H. Bürger, K. Nolte, K. Becker, M. Bulla, O. Debus, H. Rabe, E. Harms. Nekrotisierende Pneumonie mit Staphylococcus aureus (pvl-Gen positiv). Letal verlaufende Pneumonie bei einem 12-jährigen immunkompetenten Mädchen. Monatsschr. Kinderheilkd. 155 (S1) 2007 S10-S15
K. Becker, I. Pagnier, B. Schuhen, F. Wenzelburger, A.W. Friedrich, F. Kipp, G. Peters, C. von Eiff. Does Nasal Cocolonization by Methicillin-Resistant Coagulase-Negative Staphylococci and Methicillin-Susceptible Staphylococcus aureus Strains Occur Frequently Enough to Represent a Risk of False-Positive Methicillin-Resistant S. aureus Determinations by Molecular Methods? J. Clin. Microbiol.44 (1) 2006 229-231
K. Becker, N. A. Laham, W. Fegeler, R.A. Proctor, G. Peters, C. von Eiff. Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in Staphylococcus aureus small colony variants. J. Clin. Microbiol. 44 (9) 2006 3274-3278
J. Seggewiß, K. Becker, O. Kotte, M. Eisenacher, M.R. Khoschkhoi Yazdi, A. Fischer, P. McNamara, N. Al Laham, R. Proctor, G. Peters, M. Heinemann, C. von Eiff. Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small colony variant phenotype. J. Bacteriol. 188 (22) 2006 7765-7777
C. von Eiff, P. McNamara, K. Becker, D. Bates, X.-H. Lei, M. Ziman, B.R. Bochner, G. Peters, R.A. Proctor. Phenotype Microarray Profiling of Staphylococcus aureus menD and hemB Mutants with the Small-Colony-Variant Phenotype. J. Bacteriol. 188 (2) 2006 687-693
A. Mellmann, K. Becker, C. von Eiff, U. Keckevoet, P. Schumann, D. Harmsen. Sequencing and staphylococci identification. Emerg. Infect. Dis. 12 (2) 2006 333-336
G. Blaiotta, V. Fusco, C. von Eiff, F. Villani, K. Becker. Biotyping of enterotoxigenic Staphylococcus aureus by enterotoxin gene cluster (egc) polymorphism and spa-typing analyses. Appl. Environ. Microbiol. 72 (9) 2006 6117-6123
F. Sachse, C. von Eiff, W. Stoll, K. Becker, C. Rudack. Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitis. Clin. Exp. Immunol. 144 (3) 2006 534-542
A. Florax, K. Ehlert, K. Becker, J. Vormoor, A.H. Groll. Bordetella pertussis Respiratory Infection Following Hematopoietic Stem Cell Transplantation: Time for Universal Vaccination? Bone Marrow Transplant. 38 (9) 2006 639-640
C. Breitkopf, D. Hammel, H. H. Scheld, G. Peters, K. Becker. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 111 (11) 2005 1415-1421
C. Aepinus, C. Spang, A. Podbielski, K. Becker, B. Zimmermann, C. Plath, C. von Eiff. Staphylococcus aureus infection caused by a Panton Valentine leucocidin-producing strain. Ped. Infect. Dis. J. 24 (3) 2005 284-285
K. Becker, C. von Eiff, B. Keller, M. Brück, J. Etienne, G. Peters. Thermonuclease gene as a target for specific identification of Staphylococcus intermedius isolates: Use of a PCR-DNA enzyme immunoassay. Diagn Microbiol. Infect. Dis. 51 (4) 2005 237-244
F. Kipp, B.C. Kahl, K. Becker, E.J. Baron, R.A. Proctor, G. Peters, C. von Eiff. Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small colony variants. J. Clin. Microbiol. 43 (4) 2005 1956-1959
B. Loddenkötter, K. Becker, C. Hohoff, B. Brinkmann, T. Bajanowski. Real-time quantitative PCR assay for the detection of Helicobacter pylori: no association with sudden infant death syndrome. Int. J. Legal Med. 119 (4) 2005 202-206
I. Mohammedi, C. Berchiche, K. Becker, K. Belkhouja, D. Robert, C. von Eiff, J. Etienne. Fatal Kytococcus schroeteri bacteremic pneumonia. J. Infect. 2005 51 (2) E11-E13
H. Seifert, D. Oltmanns, K. Becker, H. Wisplinghoff, C. von Eiff. Staphylococcus lugdunensis pacemaker-related infection. Emerg. Infect. Dis. 11 (8) 2005 1283-1286
C. von Eiff, A.W. Friedrich, K. Becker, G. Peters. Comparative in vitro Activity of Ceftobiprole against Staphylococci Displaying Normal and the Small-Colony Variant Phenotype. Antimicrob. Agents Chemother. 49 (10) 2005 4372-4374
C. von Eiff, G. Lubritz, C. Heese, G. Peters, K. Becker. Effect of trimethoprim-sulfamethoxazole prophylaxis in AIDS patients on the formation of the small colony variant phenotype of Staphylococcus aureus. Diagn. Microb. Infect. Dis. 48 (3) 2004 191 –194
F. Kipp, K. Becker, G. Peters, C. von Eiff. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J. Clin. Microbiol. 42 (3) 2004 1277-1279
C. von Eiff, A.W. Friedrich, G. Peters, K. Becker. Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn. Microb. Infect. Dis. 49 (3) 2004 157 –162
T. Kuczius, A. Buschmann, W. Zhang, H. Karch, K. Becker, G. Peters,M. H. Groschup. Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding. Biol. Chem. 385(8) 2004 739-747
K. Becker, D. Harmsen, A. Mellmann, C. Meier, P. Schumann, G. Peters, C. von Eiff. Development and evaluation of a quality-controlled ribosomal sequence database for 16S rDNA-based identification of Staphylococcus species. J. Clin. Microbiol. 42 (11) 2004 4988-4995
K. Becker, A. W. Friedrich, G. Peters, C. von Eiff. Systematic survey on the prevalence of genes coding for staphylococcal enterotoxins SElM, SElO, and SElN. Mol. Nutr. Food Res. 48 (7) 2004 488-495
K. Becker, A. W. Friedrich, G. Lubritz, M. Weilert, G. Peters, C. von Eiff. Prevalence of genes coding for pyrogenic toxin superantigens and exfoliative toxins in blood and nasal strains of Staphylococcus aureus. J. Clin. Microbiol. 41 (4) 2003 1434-1439
F. Kipp, W. Ziebuhr, K. Becker, V. Krimmer, N. Höß, G. Peters, C. von Eiff. Detection of Staphylococcus aureus by 16S rRNA directed in situ hybridisation in a patient with a brain abscess caused by small colony variants. J. Neurol. Neurosurg. Psychiatry 74 (7) 2003 1000-1002
F. Schmäl, W. Fegeler, H.J. Terpe, W. Hermann, W. Stoll, K. Becker. Bacteria and granulation tissue associated with Montgomery T-tubes. Laryngoscope 113 (8) 2003 1394-1400
A. Chowdhary, K. Becker, W. Fegeler, H.C. Gugnani, L. Kapoor, V.S. Randhawa, G. Mehta. An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses 46 (8) 2003 269-274
H.C. Gugnani, K. Becker, W. Fegeler, S. Basu, D. Chattopadhya, U. Baveja, S. Satyanarayana, T. Kalghatgi, A. Murlidhar. Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses 46 (8) 2003 281-288
C. von Eiff, J.F. Kokai-Kun, K. Becker, G. Peters. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood. Antimicrob. Agents Chemother. 47 (11) 2003 3613-3615
K. Becker, J. Wüllenweber, H.-J. Odenthal, M. Moeller, P. Schumann, G. Peters, C. von Eiff. Prosthetic Valve Endocarditis Due to Kytococcus schroeteri. Emerg. Infect. Dis. 9 (11) 2003 1493-1495 (letter)
B.C. Kahl, K. Becker, A.W. Friedrich, J. Clasen, B. Sinha, C. von Eiff, G. Peters. agr-dependent bacterial interference has no impact on long-term colonization of Staphylococcus aureus during persistent airway infection of cystic fibrosis patients. J. Clin. Microbiol. 41 (11) 2003 5199-5201
W. Förster, K. Becker, D. Hungermann, H. Busse. Methicillin-resistant Staphylococcus aureus keratitis after excimer laser photorefractive keratectomy. J. Cataract Refract. Surg. 28 (4) 2002 722-724
K. Becker, P. Schumann, J. Wüllenweber, M. Schulte, H.-P. Weil, E. Stackebrandt, G. Peters, C. von Eiff. Kytococcus schroeteri sp. nov., a novel Gram-positive actinobacterium isolated from a human clinical source. Int. J. Syst. Evol. Microbiol. 52 (5) 2002 1609-1614
D. Bettin, G. Schaphorn, S. Blasius, K. Becker, T. Niemeyer. A rare case of Salmonella osteomyelitis in the humerus as a differential diagnosis to a malignant bone tumor. Arch. Orthop. Trauma Surg. 122 (9/10) 2002 544-546
K. Becker, D. Badehorn, B. Keller, M. Schulte, K. H. Böhm, G. Peters, W. Fegeler. Isolation and characterization of a species-specific DNA fragment for identification of Candida (Torulopsis) glabrata by PCR. J. Clin. Microbiol. 39 (9) 2001 3356-3359
B. Dose, J. Köhring, K. Becker, J. Ritter, J.H. Brämswig, E. Harms. Viszerale Leishmaniose - nicht nur eine Tropenkrankheit. (Case report)Monatsschr. Kinderheilkd. 149 (10) 2001 1054-1058
M. Hussain, K. Becker, C. von Eiff, G. Peters, M. Herrmann. Analogs of Eap protein are conserved and prevalent in clinical Staphylococcus aureus isolates. Clin. Diagn. Lab. Immunol. 8(6) 2001 1271-1276
M. Hussain, K. Becker, C. von Eiff, J. Schrenzel, G. Peters, M. Herrmann. Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J. Bacteriol. 183 (23) 2001 6778-6786
K. Becker, B. Keller, C. von Eiff, M. Brück, G. Lubritz, J. Etienne, G. Peters. Enterotoxigenic potential of Staphylococcus intermedius. Appl. Environ. Microbiol. 67 (12) 2001 5551-5557
C. von Eiff, K. Becker, K. Machka, H. Stammer, G. Peters for the Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344 (1) 2001 11-16
C. von Eiff, K. Becker, D. Metze, G. Lubritz, J. Hockmann, T. Schwarz, G. Peters. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: A cause for antibiotic treatment failure in a patient with Darier's disease. Clin. Infect. Dis. 32 (11) 2001 1643-1647
K. Becker, G. Haverkämper, C. von Eiff, R. Roth, G. Peters. Survey of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene in non-Staphylococcus aureus species. Eur. J. Clin. Microbiol. Infect. Dis. 20 (6) 2001 407-409
K. Becker, D. Badehorn, S. Deiwick, G. Peters, W. Fegeler. Molecular genotyping of Candida species with special respect to Candida (Torulopsis) glabrata strains by arbitrarily primed PCR. J. Med. Microbiol. 49 (6) 2000 575-581
P. Ellinghaus, D. Badehorn, R. Blümer, K. Becker, U. Seedorf. Increased efficiency of arbitrarily primed PCR by prolonged ramp times. Biotechniques 26 (4) 1999 626-630
J. Denecke, K. Becker, H. Jürgens, R. Gross, J.E.A. Wolff. Falsification of tetrazolium dye (MTT) based cytotoxicity assay results due to Mycoplasma contamination of cell cultures. Anticancer Res. 19 (2A) 1999 1245-1248
K. Becker, C. Ortmann, T. Bajanowski, B. Brinkmann, G. Peters. Use of polymerase chain reaction for postmortem diagnosis of malaria. Diagn. Mol. Pathol. 8 (4) 1999 211-215
B. Kahl, M. Herrmann, A. Schulze Everding, H.G. Koch, K. Becker, E. Harms, R.A. Proctor, G. Peters. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177 (4) 1998 1023-1029
K. Becker, R. Roth, G. Peters. Rapid and Specific Detection of Toxigenic Staphylococcus aureus: Use of Two Multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin Genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J. Clin. Microbiol. 36 (9) 1998 2548-2553
W.A. Müller, G. Koch, K. Becker, E. Philipp, A. Wohlfahrt. Die Erfassung von zirkulierendem Toxoplasma-Antigen durch monoklonale Antikörper.Mitt. Österr. Ges. Tropenmed. Parasitol. 13 1991 165-176
W.A. Müller, G. Koch, K. Becker. Tierexperimentelle Untersuchungen zum Nachweis von zirkulierendem Toxoplasma-Antigen. Angew. Parasitologie 32 (2) 1991 93-98
W.A. Müller, A. Wohlfahrt, G. Koch, H. Lauf, K. Becker, H.-L. Borkhardt. Nachweis von zirkulierendem Toxoplasma-Antigen in Patientenseren mit monoklonalen Antikörpern in einem Enzymimmunassay. Z. Klin. Med. 44 1989 1943-1946
W.A. Müller, K. Becker, A. Schäfer, G. Koch, H.-L. Borkhardt. Die Gewinnung von Hybridzellen, die monoklonale Antikörper gegen Toxoplasma gondii produzieren. Angew. Parasitol. 29 (1) 1988 11-17


The 180 outdoor seating collection by Gloster is practical in design with a modern twist in style and comfort. The frame of the chairs is handcrafted with premium aluminum and finished with a powder coating that is extremely resistant in the harshest weather conditions. The sling seat and back are made from a soft luxurious fabric to give you structured comfort. Both materials are easy to clean and will last through the years.
Create your outdoor space with your personal touch. Choose between two color combinations of meteor (frame) with charcoal (sling) or white (frame) with white (sling). Use 180 next to your pool or pair it with Gloster's modern dining tables, Carver or Split, for your outdoor dining experience. Add to your 180 ambience with Gloster's Outdoor Lighting.


At tributek, we strive to deliver quality, value, and snappy service.
If you have any questions or comments, please e-mail (we check several times each day). When e-mailing, please give complete information about who you are, an address and a phone number. We reserve the right to not respond to what appear to us to be crank e-mails.
Warranty for each item is explained in the text describing the item on the site. If a paper warranty document is supplied with the item it supersedes any warranty information appearing on the site. Customer always pays all shipping costs, both directions, associated with a warranty return. Please e-mail us for a RMA number before returning anything.
A 20% restocking fee will be charged for all new items returned. Used items may not be returned. Please e-mail for a RMA number before returning anything.
All items are EX WORKS Elburn Illinois USA INCOTERMS (domestic FOB Elburn Illinois). No exceptions. Items shipped to an Illinois address not used directly in factory production will have 7% Illinois sales tax added to the item.
We are committed to re-using and/or re-purposing packaging wherever practical. While some high value items, particularly converters, have dedicated new packaging that is specifically designed to protect that item, if we are shipping multiple items or shipping smaller items we will look to our large stock of used packaging and inner packing that accumulates as we receive things. Almost everything comes in corrugated containers that are usually recycled once opened and inner packaging such as air pouches and bubble wrap that is usually thrown away. If these items are clean and usable we save them and ship our product in them. We usually turn the boxes inside out so that your receiving department is not confused by the lettering or graphics on the box. We will re-use retail packaging as well as shipping boxes. Our customers have received shipments in boxes that originally held everything from electronics parts to cell phones to corn dogs to eggs to golf balls to construction supplies. This saves us a lot of money buying boxes (which keeps us a value leader in our industry) and maybe keeps something out of a landfill just a little longer or saves a tree here or there. Re-using packaging is even more efficient than recycling it. Even if you don't support us in this we at least hope it doesn't bother you.
We believe in keeping it simple, so that's about it. We hope you find us easy to do business with.


Your access to and use of WebbRocks website ("the Website") is subject exclusively to these terms and conditions. You will not use the website for any purpose that is unlawful or prohibited by these terms and conditions. If you do not accept these terms and conditions you must immediately stop using the website else it will be termed as your acceptance.
WebbRocks will carry out work only where a written purchase/work/service/maintenance order is sent via email or submitted by our online support form.
3.1 Change or remove (temporarily or permanently) the website or any part of it without notice. WebbRocks shall not be liable to you for any such change or removal.
Though every effort will be made to ensure that the website and any work done by us is free of errors but WebbRocks cannot accept responsibility for any losses incurred due to malfunction, the website or any part of it. The web server, website, graphics and any programming code remain the property of WebbRocks until all outstanding accounts are paid in full. Any work done (unless specifically agreed) by WebbRocks remain the copyright of WebbRocks and may only be commercially reproduced or resold with the permission of WebbRocks.
WebbRocks cannot take responsibility for any copyright infringements caused by materials submitted by the client.
Any additions to the brief will be carried out at the discretion of WebbRocks and where no charge is made by WebbRocks for such additions, WebbRocks accept no responsibility to ensure such additions are error free and reserve the right to charge an according amount for any correction to these or further additions.
WebbRocks will not be liable for any costs incurred, compensation or loss of earnings due to the work carried out on behalf of the client or any of the clients appointed agents.
WebbRocks will not be liable for any costs incurred, compensation or loss of earnings due to the unavailability of the site, its servers, software or any material provided by its agents.
WebbRocks cannot take responsibility for any losses incurred by the use of any software created for the client. Whilst every care has been taken to ensure products are problem free and accurate, the ultimate responsibility lies with the client in ensuring that all software is functioning correctly before use.
Where applications or sites are developed on servers not provided by WebbRocks, the client is expected to provide or seek any information, additional software, support or co-operation pertaining to the server required in order for the application to be correctly developed. Where large applications are to be developed, it is the client's responsibility to provide a suitable testing environment which is identical to the final production environment.
The client is expected to test fully any application or programming relating to a site developed by WebbRocks before being made generally available for use. Where "bugs", errors or other issues are found after the site is live, WebbRocks will endeavor (but is not obliged to) to correct these issues to meet the standards of function outlined in the brief.
Whilst WebbRocks offers hosting of websites, no guarantees can be made as to the availability or interruption of this service by WebbRocks cannot accept liability for losses caused by the unavailability, malfunction or interruption of this service.
WebbRocks reserves the right to refuse to handle in any way, material which may be deemed offensive, illegal or in any way controversial. Fees relating to web hosting or domain names must be paid prior to the expiration date of the said service. If the fees remain unpaid at the time of expiration, WebbRocks can cancel the said service and not liable for any data lost as a result of the cancellation.
7.1 All copyright, trade marks and all other intellectual property rights in the website and its content (including without limitation the website design, text, graphics and all software and source codes connected with the Website) are owned by or licensed to WebbRocks or otherwise used by WebbRocks as permitted by law.
8.1 The Website is provided on an "AS IS" and "AS AVAILABLE" basis. To the extent permitted by law, WebbRocks will not be liable for any indirect or consequential loss or damage whatever (including without limitation loss of business, opportunity, data, profits) arising out of or in connection with the use of the website.
8.2 WebbRocks makes no warranty that the functionality of the website will be uninterrupted or error free, that defects will be corrected or that the website or the server that makes it available are free of viruses or anything else which may be harmful or destructive.
A deposit may be required from a new client before any work is carried out. In all cases, website hosting fees and any costs incurred by WebbRocks on behalf of the client are payable in advance and are non-refundable.
It is the WebbRocks policy that any outstanding accounts for work carried out by WebbRocks or its affiliates are required to be paid in full, no later than 30 days from the date of the invoice unless by prior arrangement with WebbRocks. If accounts are not settled or WebbRocks has not been contacted regarding the delay, access to the related website may be denied. Fees relating to web hosting or domain names must be paid prior to the expiration date of the said service. If the fees remain unpaid at the time of expiration, we will with immediate effect, cancel said service and any data held by said service will be removed.
Full refund: In cases, where the project has not been started or if the initial design style has not been approved. We will intiate the full refund.
Note: Any charges levied as tax is not eligible for refund.
Refund Process: Please connect with our customer care via Online Form or call. The customer care team will validate the request by checking the timelines, service type, etc and shall take the request for refund.
Conditions: There is no provision for compensation for the delay of service under any conditions, until and unless there is an agreement signed with a penalty clause for delay in delivery.
WebbRocks may at any time, without prior notice under its sole discretion, amend the terms and conditions from time to time. You are therefore requested to review this policy periodically. Your continued use of WebbRocks website after any such amendments automatically implies your acceptance of the same thereof.


The Professional Pricing Society's (PPS) annual spring conference in Chicago is the perfect playground for data-driven marketers, analytical pricers, and efficiency focused program managers.
At the conference earlier this month, we talked about tactical methods for price improvement, discussed how to collaborate with sales, and challenged age-old economic theory.
One question that came up in in a workshop I presented and then again throughout the conference was: "If you lower the price, will they come?" In more clinical terms, the question challenges a basic view of economic elasticity that dictates your volume will increase in correlation to your price decrease.
In fact, there are five key things that appear nowhere in standard economic models: status, certainty, autonomy, relatedness, and fairness. For example, a branded product may offer me certainty in a product's quality that I would not have with an alternate choice. Relatedness refers to how consumers make selections in reference to the other choices in the immediate transaction, i.e. when offered best, better, and good enough options the selection is often the "better" option, an interesting reflection on many consumer's opposing fears of high cost and low quality.
Other sessions discussed how important it is for a pricer to get out of the office — and I mean this as a euphemism for becoming more engaged with other core departments and business functions. Some of the most popular sessions were those that touched on influencing sales. As a former pricer myself, I realize I spent far too much time with my head in a spreadsheet instead of considering all of the influences on pricing beyond what's captured in a contract or transaction.
At PROS, our approach provided tools that consider both the pricer's objectives as well as the salesperson's objectives to maximize the successful outcomes that help your business to realize both your revenue and profitability goals. PPS is moving in this direction as well with dedicated programming focusing onconfigure, price, quote (CPQ) and its role in price execution.
Like just about every other transactional business process these days, data-driven analytics for CPQ is a hot topic, but there is often a significant spread between what is advertised and what is actually delivered. PROS is participating in a PPS webinar on Wednesday, May 18 at 12pm EDT on data science and CPQ. We will discuss some of the exciting analytics trends in CPQ as well as try to separate myth from reality. The webinar is open to everyone and you can register here.


text:
<!doctype html>

    <title><?php echo $tool['name']; ?> Demos</title>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="<?php echo $tool['desc']; ?>">
    <meta http-equiv="cleartype" content="on">
    <link href="<?=base_url()?>css/bootstrap.min.css" rel="stylesheet">
    <link href="<?=base_url()?>css/bootstrap-responsive.min.css" rel="stylesheet">
    <link rel="shortcut icon" type="image/x-icon" href="favicon.ico">

                    <?php foreach($item_list as $_item): ?>

<?php echo $_item['title']; ?>

<?php echo $_item['desc']; ?>

                                 <a target="_blank" href="<?=site_url('item/'.$_item['id'])?>"><img style="width:400px;height:300px" src="<?php echo $_item['pic_url']; ?>" alt="">

                    <?php endforeach; ?>

	<?php echo $this->pagination->create_links();?>

redpajama_set_name: RedPajamaGithub


Audition Requirements: Auditions are held at the beginning of each semester and are open to the entire university community. Check with the Band office for details.
The University of Kentucky Wind Symphony consists of the finest wind and percussion graduate and undergraduate students in the nationally recognized UK School of Music. As the centerpiece of a band program that has served the Commonwealth of Kentucky for over 100 years, the Wind Symphony continues a rich tradition of performing the finest traditional and contemporary compositions in the concert band / chamber winds repertoire.
The UK Wind Symphony has been invited to perform at many of the most prestigious events in the college band profession, including recent appearances at the College Band Directors National Association National Conferences at the University of North Carolina - Greensboro, University of Minnesota, and the University of Georgia. The Wind Symphony has also been recently invited to perform at the CBDNA Southern Division Conferences in Nashville, Tennessee, and Oxford, Mississippi, and at the annual conference of the Kentucky Music Educator's Association, held annually in Louisville.
In 2008, the Wind Symphony traveled to the People's Republic of China and performed for thousands of Chinese citizens in person and via broadcast during a ten-day concert tour of several of China's most prominent cities and highly recognized concert venues.
UK School of Music Bands Twitter UK School of Music Bands - Click this icon to visit the UK Bands Twitter feed.
UK School of Music Bands Facebook UK School of Music Bands - Click this icon to visit the UK Bands Facebook Page.


text:
Ruffin-Roulhac House, also known as Little Hawfields, is a historic home located at Hillsborough, Orange County, North Carolina, United States.  It was built about 1820, and is a -story, five bay, frame dwelling including a two-room addition built about 1830.  It is topped by a gable roof, is sheathed in weatherboard, and has a one-bay 20th century replacement porch.  The interior has Federal, Greek Revival, and Victorian style design elements.  It was the home of jurist Thomas Ruffin (1787–1870) from after the end of the American Civil War until his death in 1870.

The house has since been converted into town offices for the town of Hillsborough.

It was listed on the National Register of Historic Places in 1971.  It is located in the Hillsborough Historic District.

References

External links

Historic American Buildings Survey in North Carolina
Houses on the National Register of Historic Places in North Carolina
Federal architecture in North Carolina
Greek Revival houses in North Carolina
Victorian architecture in North Carolina
Houses completed in 1820
Hillsborough, North Carolina
Houses in Orange County, North Carolina
National Register of Historic Places in Orange County, North Carolina
Individually listed contributing properties to historic districts on the National Register in North Carolina

redpajama_set_name: RedPajamaWikipedia


Facilities that perform sensitive tests walk the narrow path between performing high quality, reliable tests that are often used to make vital decisions and providing those tests in a cost effective and timely manner. Empirical Bioscience makes that path less daunting with its superior reagents, rigorous process control and deep toolbox of experience in PCR master mixes.
Whether the goal is to find an acceptable match for human tissue or to trace the source of an infectious disease transmitted through contaminated vegetables, every test requires absolute confidence that the reagents are pure, have robust activity and remain potent over time. With the single-minded purpose to be the preeminent provider of PCR reagents, Empirical Bioscience makes it its business to provide only the purest master mixes that have been assayed for the right concentrations of components and found free of rogue DNA and nuclease.
Customers that use Empirical Bioscience components and master mixes say they have been able to simplify tests, perform tests faster and improve accuracy, all the while driving down operational costs.
Empirical Bioscience takes the guesswork out of whether reagents used for tests contain rogue DNA or nuclease that can greatly reduce a shelf life of its products. By rigorously enforcing lot-to-lot consistency, Empirical Bioscience provides top-quality reagents that greatly diminish the chances that standard tests will yield false negatives or false positives due to contamination.
Some of Empirical Bioscience customers include histology labs that match donor tissues with recipients, labs that perform paternity testing and diagnostic genetic testing, and companies involved with pharmacogenomics.
But regardless of the test's purpose, it's clear that a well designed recipe made up of pure components saves time, reduces human error and improves accuracy — critical considerations for maintaining profit margins. Empirical Bioscience has extensive experience in designing complex master mixes for multiplexing to save technicians time in conducting tests.
Genetics tests for detection of bovine viral diarrhea (BVD) virus and MAD cow disease have improved the overall safety of the beef and dairy products in the food supply chain during the past decade, and experts say that trend line will only strengthen. Empirical Bioscience products are used by some of the country's largest institutions involved in the safety of plant and animal foodstuffs, such as the U.S. Department of Agriculture and Michigan State University.
With experience in developing custom master mixes used to test DNA from animals ranging from bacteria to mammals, Empirical Bioscience stands ready to make reagents that can form the backbone of reliable and affordable diagnostics.
Scientists began to apply the genomic tools used to develop new drugs and medical therapies to the plant kingdom in the mid 1990s, fueling explosive growth in the use of advanced PCR techniques to decipher plant genomes. Empirical Bioscience products are being used today in developing tests for detection of diseases caused by fungal and bacterial pathogens in vegetables and field crops of northern and central California.
To supply this burgeoning field of molecular research with the right tools, Empirical Bioscience has developed what it believes to be the most effective G-C enhancer on the market today for research of G-C rich targets and a customized version that can multiplex to save experiment steps. Due to their extensive experience in developing reagents for challenging PCR, Empirical Bioscience experts have been able to develop standard and customized multiplex products that may have more than 75 chemical components to save technicians time as they conduct their experiments.
Sign up to receive periodic updates about new products and special offers.


text:
Az M12 egy 120 mm-es aknavető, amely az ausztriai székhelyű Hirtenberger Defence Systems (HDS) gyárt. A Hirtenbergert 2019-ben a magyar állam megvásárolta, így ez a cég lesz várhatóan a Honvédség elsődleges aknavető és aknagránát beszállítója. 2021-ben a Honvédség "vontatott 120 mm-es aknavetők beszerzését kezdeményezte". A Hirtenberger M12-es aknavetőjéből  a magyar haderő "alacsony két számjegyű mennyiséget" szerzett be. A nehéz aknavetők 2023-tól állnak szolgálatba várhatóan.

Kialakítása és jellemzői
Az M12 egy teljesen "hagyományos" kialakítású 120 mm-es aknavető: amely egy vetőcsőből, egy villaállványból, valamint egy talpból áll. A könnyebb mozgatás érekében egy egytengelyes utánfutó is tartozik hozzá, amelyről gyakorlott személyzettel 45 másodperc alatt lehet letelepíteni és tűzkésszé tenni az aknavetőt. Az aknavető tömege utánfutóval mintegy háromnegyed tonna.

Az aknavető kétféle csőhosszal készül: 1900 mm (M12–1535) és 1750 mm (M12–1385). Az elsütés történhet fix ütőszeggel vagy elsütő szerkezet segítségével. Előbbi esetben amint a cső aljára ér az aknagránát, azonnal beindulnak a kivetőtöltetek, az utóbbi esetben manuális elsütés szükséges a lövéshez. Az irányzást egy 2,6x nagyítású 9 fokos látószögű NATO szabványoknak megfelelő optikai irányzék segíti. A lőelemek kiszámításához egy kézi számítógépet és szoftvert is kínál a Hirtenberger Defence Systems.

Lőszerek
A HDS aknavetőlőszerek széles választékát is gyártja 120 mm űrméretben.

 Repeszromboló (HE-TNT Mk.2) - csapódó és föld felett működésbe lépő közelségi gyújtóval egyaránt elérhető ez a lőszer típus. Több mint  repeszt szór szét robbanáskor, amiből 2300 legalább 0,56 g tömegű.  Hossza: 753 mm, tömege: 14,6 kg
 Fokozott repeszhatású repeszromboló (HE-CONFRAG Mk.3) - "60%-kal halálosabb" a gyártó szerint;  repeszt szór szét robbanáskor, amiből 3929 legalább 0,56 g tömegű. Csapódó és föld felett működésbe lépő közelségi gyújtóval egyaránt elérhető ez a lőszer típus.  Hossza: 753 mm, tömege: 14,6 kg
 Gyakorló (PRACTICE) - ballisztikailag megegyezik a repeszromboló gránátokkal, de csak egy kis méretű jelző töltetet tartalmaz a becsapódás helyének láthatóvá tétele miatt.  Hossza: 753 mm, tömege: 14,6 kg
 Füstfejlesztő, fehérfoszfor-töltetű (SMK-WP Mk.2) - gyors füstfüggöny fejlesztés  Hossza: 753 mm, tömege: 14,6 kg
 Füstfejlesztő, titán-tetraklorid-töltetű (SMK-TTC Mk.2) - nagyon gyors füstfüggöny fejlesztés  Hossza: 753 mm, tömege: 14,6 kg
 Füstfejlesztő, vörösfoszfor-töltetű (SMK-RP Mk.3) - füstfüggöny legalább 140 másodpercen át  Hossza: 841 mm, tömege: 14,8 kg
 Látható fénnyel világító gránát (ILL-VIS Mk.3) - fényerő: nagyobb mint ; Működési idő: 50 másodperc; ereszkedési sebesség: 5 m/s  Hossza: 841 mm, tömege: 14,8 kg
 Infravörös fénnyel világító gránát (ILL-IR Mk.3) - magas infravörös kisugárzás, alacsony láthatóság, Működési idő: 50 másodperc; ereszkedési sebesség: 5 m/s  Hossza: 841 mm, tömege: 14,8 kg

Források, jegyzetek

Aknavetők
Ausztria hadereje


text:
SandSerpent
BGT History - Busch Gardens Tampa History > Attractions > Roller Coasters > SandSerpent
SandSerpent (sometimes listed as Sand Serpent) is a steel wild mouse style roller coaster located in the Pantopia section of the park.
Open Date: February 2004
Location: Pantopia
Height: 46 ft
Length: 1,214 ft
Inversions: 0
The roller coaster opened in the Timbuktu section of Busch Gardens Tampa in February 2004; it had previously operated at Busch Gardens Williamsburg as Wild Izzy in 1996 and Wild (or Wilde) Maus from 1997 to 2003. When it was relocated to Busch Gardens Tampa, it was named Cheetah Chase from the time it opened at the park until 2011 when it was renamed to avoid confusion with the new Cheetah Hunt roller coaster.
SandSerpent closed unannounced on January 2, 2017, and was later added to the park's list of attraction refurbishments with a completion date of To Be Determined. Testing of the ride began in early May, and the coaster reopened on May 12.
In June 2017, a permit was filed with the City of Tampa to enclose SandSerpent and its queue inside of a new structure. The proposed structure would encompass over 5,000 square feet and reach 64 feet in height at the tallest point. Testing of the site included four borings to see if the plot of land would support the added weight of the structure. Updates to the permit application the following month noted the building would be air conditioned. Listed as "BGT 2018 Project," the park never officially announced any work and the permit would eventually expire without further progress.
Additional details and images on SandSerpent will be added in the future.
"Coasters by the Numbers" Fact Sheet, Busch Gardens Tampa Bay 8/16/2016
rcdb | Sand Serpent – accessed 9/4/2016
Busch Gardens Tampa Bay | Aug 15 2016 – accessed 8/3/2018
Twitter – @androckb | Apr 2 2017– accessed 11/15/2020
Twtiter – @androckb | May 16 2017 – accessed 11/15/2020
Twitter – @androckb | Jul 20 2017 – accessed 12/15/2020

redpajama_set_name: RedPajamaCommonCrawl


Gingerbread pumpkin cupcake with vanilla buttercream, garnished with a sugared cranberry.
Decorate with white chocolate stars, Candied cherries, sliced almonds & currants, or sugared cranberries.
The gifts I've bought are now wrapped up and nestled under the tree, and I'm rapidly checking things off my Christmas to-do list, which is a great feeling... but nothing beats the smell of warm gingerbread and spices that's currently wafting through the house from the kitchen. I know, I know: cupcakes are played out and boring these days, but if you think so, it's only because you haven't had these ones. I whipped up the gingerbread pumpkin cupcakes today from a 'from-scratch' recipe in the box (called, mysteriously, Colonial Gingerbread) because I couldn't find any gingerbread cake mix at the shops. But if you can, then you're welcome to make this with cake mix, as Ms. Crocker originally intended. However, this colonial gingerbread recipe requires only one bowl, cooks in 20 minutes, and is so delicious I'd really encourage you to make it. From the quantities below, you'll get about 9 cupcakes or 2 small loaves of gingerbread-- note that this cake is delicious by itself and you could serve them as muffins without frosting, or feel free to frost them up as per the below if you're looking for something a little more festive.
5 spoons out of five. Pumpkin is incredibly hard to find in the UK and insanely expensive in cans when you do find it, so I don't like to waste it on recipes I'm not sure will be good. But these cupcakes did not disappoint and were totally worth cracking open my last can of pumpkin purée for. These are a perfect party food and honestly I wish I had made them for our party last week, but alas, I didn't know about them then. Oh well, here we are and they taste delicious. Enjoy!
Into large bowl, combine all ingredients.
Beat well until blended but not completely smooth (a few lumps will help it rise).
Fill muffin cups 2/3 full with batter and bake 20 minutes or until a pick inserted in the center comes out clean.
Cool and frost with vanilla buttercream frosting and decorate as you wish.


text:
Workhorse to Exhibit W-15 Electric Pickup Truck at the National Drive Electric Week™ Event in Cincinnati September 9
Workhorse Group Inc.
CINCINNATI, Sept. 6, 2017 /PRNewswire/ -- Workhorse Group Inc. (NASDAQ: WKHS), a Cincinnati-based technology company focused on providing electric mobility solutions to the transportation sector, today announced that it will exhibit the new W-15 electric range-extended pickup truck at the National Drive Electric Week™ event at Cincinnati's Tri-County Mall on September 9. The truck will be on display and available for test drives from 10:00 a.m. to 3:00 p.m.
The Workhorse W-15 light duty platform design is an extension of the E-Gen electric technology used in Workhorse medium-duty delivery trucks, and is the first plug-in range-extended electric pickup built from the ground up by an original equipment manufacturer (OEM) in America. The vehicle is designed for unlimited range, with the first 80-miles all-electric powered using Panasonic 18650 Li-ion batteries, and additional range as needed using the gasoline generator to continuously charge the battery.
The W-15 will also feature onboard exportable power, allowing individuals to operate equipment directly from the vehicle without requiring an external generator. With the goal of being the safest pickup truck in America for fleet operators, the W-15's safety features include an extra large crumple zone and lower center of gravity while still providing ground clearance. The W-15 also offers crash mitigation technologies, including automatic braking and lane centering. Once production commences, the W-15 is anticipated to have a $52,500 MSRP.
About Workhorse Group Inc.
Workhorse is a technology company focused on providing electric mobility solutions to the transportation sector. As an American original equipment manufacturer, we design and build high performance battery-electric vehicles including trucks and aircraft. We also develop cloud-based, real-time telematics performance monitoring systems that are fully integrated with our vehicles and enable fleet operators to optimize energy and route efficiency. All Workhorse vehicles are designed to make the movement of people and goods more efficient and less harmful to the environment. For additional information visit www.workhorse.com.
This press release includes forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained herein. Factors that could cause actual results to differ materially include, but are not limited to: our limited operations and need to expand in the near future to fulfill product orders; risks associated with obtaining orders and executing upon such orders; the ability to protect our intellectual property; the potential lack of market acceptance of our products; potential competition; our inability to retain key members of our management team; our inability to raise additional capital to fund our operations and business plan; our inability to maintain our listing of our securities on the Nasdaq Capital Market; our ability to continue as a going concern; our liquidity and other risks and uncertainties and other factors discussed from time to time in our filings with the Securities and Exchange Commission ("SEC"), including our annual report on Form 10-K filed with the SEC. Workhorse expressly disclaims any obligation to publicly update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE Workhorse Group Inc.
http://workhorse.com